Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.390
+0.070 (3.02%)
At close: Nov 4, 2024, 4:00 PM
2.400
+0.010 (0.42%)
After-hours: Nov 4, 2024, 4:34 PM EST

Oramed Pharmaceuticals Revenue

In the year 2023, Oramed Pharmaceuticals had annual revenue of $1.34M, down -50.43%.

Revenue (ttm)
$1.34M
Revenue Growth
-50.43%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
97.44M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M-9.00K-0.33%
Dec 31, 20212.71M9.00K0.33%
Aug 31, 20212.70M-9.00K-0.33%
Dec 31, 20202.71M2.00K0.07%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Assertio Holdings 132.19M
OptimizeRx 83.20M
MDxHealth 80.74M
Cidara Therapeutics 53.87M
Protalix BioTherapeutics 38.05M
InflaRx 113.02K
Revenue Rankings